BridgeBio Pharma, Inc. (BBIO)
$63.30-3.73%Close
SELLRECOVERY · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $12.4B
- Beta
- 0.97
- P/E (TTM)
- -17.68
- Short % float
- 11.63%
- Days to cover
- 5.8
- SI change
- -8.7%
- 1W
- -5.47%
- 1M
- -12.54%
- vs SPY 1W
- -5.33%
- vs SPY 1M
- -15.05%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on BBIO?
- LOPJLB’s latest quantitative signal on BridgeBio Pharma, Inc. (BBIO) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is BBIO in?
- BridgeBio Pharma, Inc. (BBIO) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does BridgeBio Pharma, Inc. (BBIO) do?
- BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases. Notable candidates within its development pipeline include: AG…